Hyperthermia and immunotherapy: clinical opportunities
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Hyperthermia"
DOI: 10.1080/02656736.2019.1653499
Abstract: Abstract Hyperthermia holds great promise to advance immunotherapy in the treatment of cancer. Multiple trials have demonstrated benefit with the addition of hyperthermia to radiation or chemotherapy in the treatment of wide-ranging malignancies. Similarly, pre-clinical… read more here.
Keywords: immunotherapy clinical; hyperthermia immunotherapy; hyperthermia; treatment ... See more keywords
Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.980986
Abstract: Background The tumor microenvironment is mainly composed of tumor-infiltrating immune cells (TIICs), fibroblast, extracellular matrix, and secreted factors. TIICs are often associated with sensitivity to immunotherapy and the prognosis of multiple cancers, yet the predictive… read more here.
Keywords: immunotherapy clinical; immunotherapy; tiic model; gastric cancer ... See more keywords
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1168710
Abstract: Introduction Immunotherapy is an effective treatment for a subset of cancer patients, and expanding the benefits of immunotherapy to all cancer patients will require predictive biomarkers of response and immune-related adverse events (irAEs). To support… read more here.
Keywords: immunomodulatory proteins; immunotherapy clinical; studies immunotherapy; clinical trials ... See more keywords